Search Tag: immunotherapy
2022 03 Jun
Past research has shown that women tend to have more side effects, or adverse events, from chemotherapy than men. Now a team from the SWOG Cancer Research Network that analyzed data on more than 20,000 patients from more than 200 clinical trials reports that women also have a higher risk of severe adverse events from two other major modes of cancer...Read more
2022 02 Mar
OncoMyx Therapeutics, a privately-held oncolytic virus immunotherapy company has announced the appointment of Robert Williamson as Chief Business and Chief Financial Officer. Mr. Williamson has more than two decades of experience in building, financing, and leading private and public biotechnology companies through critical phases of growth. At OncoMyx,...Read more
2019 01 May
A randomised controlled multicentre trial assessed for the first time the safety and pharmacokinetics of an antiprogrammed cell death-ligand 1 (anti–PD-L1) immune checkpoint inhibitor (BMS-936559; Bristol-Myers Squibb, Princeton, NJ) and its effect on immune biomarkers in participants with sepsis-associated immunosuppression. Results show that...Read more
2016 04 Nov
CytoSorbents Corporation , a critical care immunotherapy leader commercializing its flagship CytoSorb® extracorporeal cytokine adsorber to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced the addition of Belgium and Luxembourg to its direct sales territories. CytoSorb is now distributed in 42...Read more
2016 04 Apr
Researchers in Austria have unraveled how small cell lung cancer (SCLC) is not usually detected until it is at an advanced stage, when metastases have already formed. Chemotherapy is very effective initially but, within a year, cancer recurs and this time does not respond to a course of chemotherapy, they said. The research group headed by Gerhard...Read more
2015 22 Apr
A new technique that allows real-time, noninvasive imaging of the immune system’s response to the presence of tumours offers a potential breakthrough both in diagnostics and in monitoring efficacy of cancer therapies. Developed in the lab of Whitehead Institute Member Hidde Ploegh, the method utilises the imaging power of positron emission tomography...Read more
2015 20 Jan
Researchers at Tübingen University have developed a new technique to safely mark T-cells for non-invasive in vivo imaging to better understand what happens during immune reactions in the body. This technique enabled the investigators to track the T-cell movement in mice using positron emission technology (PET). Previous methods used to follow the movement...Read more
2014 15 Dec
According to a new study, a non-surgical injection of programmable biomaterial that spontaneously assembles in vivo into a 3D structure could fight and even help prevent cancer as well as infectious diseases such as HIV. The study, conducted by researchers at the Wyss Institute for Biologically Inspired Engineering and Harvard's School of Engineering...Read more
2014 06 Oct
Using immunotherapy and radiotherapy simultaneously to treat cancers could prevent some patients from becoming resistant to treatment, according to researchers from The University of Manchester (England, UK). Combining the two therapies enabled the immune system to hunt down and destroy cancer cells that were not killed by the initial radiotherapy in...Read more
2014 10 Sep
The FDA has approved a drug for the treatment of advanced melanoma. Pembrolizumab, which goes by the brand name Keytruda, is expected to be a game-changing drug for treating patients with advanced melanoma and who are no longer responding to alternative treatments. It is developed by Merck & Co. Keytruda is an immunotherapy drug that attacks PD-1,...Read more
2014 13 May
A study recently published in the Journal of Immunology Research reports that patients with highest levels of the most powerful version of the immune molecule HLA-G seem to have the lowest risk of rejecting their transplanted kidney. Dr. Anatolij Horuzsko, immunologist at the Medical College of Georgia at Georgia Regents University and the study's...Read more
2014 11 Mar
Together with researchers from around the UK, a team of oncologists from The Clatterbridge Cancer Centre has been conducting a project to develop a ground-breaking cancer vaccine that can be utilised alongside traditional treatment methods in order to fight pancreatic cancer. Pancreatic cancer is the fifth biggest cause of cancer related deaths,...Read more